FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372597001: Substance with alpha-2 adrenergic receptor antagonist mechanism of action (substance)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3520612012 Alpha-2 adrenergic receptor antagonist en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3520680011 Substance with alpha-2 adrenergic receptor antagonist mechanism of action (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3520852012 Substance with alpha-2 adrenergic receptor antagonist mechanism of action en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alpha-2 adrenergic receptor antagonist Is a Alpha adrenergic receptor antagonist true Inferred relationship Some
Alpha-2 adrenergic receptor antagonist This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Alpha-2 adrenergic receptor antagonist (disposition) true Inferred relationship Some
Alpha-2 adrenergic receptor antagonist Is a Substance with adrenergic receptor antagonist mechanism of action (substance) false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Atipamezole hydrochloride Is a True Alpha-2 adrenergic receptor antagonist Inferred relationship Some
Yohimbine hydrochloride Is a True Alpha-2 adrenergic receptor antagonist Inferred relationship Some
Product containing alpha-2 adrenergic receptor antagonist (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alpha-2 adrenergic receptor antagonist Inferred relationship Some 1
Product containing yohimbine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alpha-2 adrenergic receptor antagonist Inferred relationship Some
Product containing methyltestosterone and pemoline and yohimbine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alpha-2 adrenergic receptor antagonist Inferred relationship Some
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alpha-2 adrenergic receptor antagonist Inferred relationship Some
Yohimbine (substance) Is a True Alpha-2 adrenergic receptor antagonist Inferred relationship Some
Deserpidine (substance) Is a True Alpha-2 adrenergic receptor antagonist Inferred relationship Some
Atipamezole (substance) Is a True Alpha-2 adrenergic receptor antagonist Inferred relationship Some

This concept is not in any reference sets

Back to Start